Back to Main

Faculty Detail    
Name KIRBY I BLAND
Professor and Chairman Department of Surgery
 
Campus Address BDB 503 Zip 0012
Phone  205-975-2190
E-mail  kbland@uab.edu
Other websites
     

Education
Undergraduate  Auburn University    1964  BS 
Medical School  University of Alabama    1968  MD 
Residency  University of Florida College of Medicine     1969  None 
Residency  University of Florida College of Medicine    1976  None 
Fellowship  University of Texas / MD Anderson Hopital and Tumor Institute    1977  None 

Certifications
Diplomate National Board of Medical Examiners  1969 
The American Board of Surgery  1978 
The American Board of Surgery: Recertification   1991, 2000 


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Surgery   Surgery - General Surgery Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Professor
Center  General Clinical Research Center  Ctr for Clinical & Translational Sci Professor
Center  Medicine  Gene Therapy Center Professor

Graduate Biomedical Sciences Affiliations
Integrative Biomedical Sciences 

Biographical Sketch 
Kirby I Bland, M.D. is the Fay Fletcher Kerner Professor and Chairman of UAB's Department of Surgery and Surgeon-in-Chief of UAB's Department of Surgery hospitals and clinics as well as providing leadership to the Comprehensive Cancer Center. Dr. Bland is internationally renowned for his contributions to surgical oncology and for his distinguished career as a general surgeon, researcher and editor.

In addition to his administrative roles at UAB, Dr. Bland continues to maintain a clinical practice, operating and seeing patients 4 days a week.

Dr. Bland's research influence is far reaching. He has been a Principle Investigator/Program Leader of the Cancer Center's $13.9-million SPORE (Specialized Program of Research Excellence) and continues to be the Principal Investigator on UAB's T-32 Training Grant in Surgical Oncology. His scientific focus and research remains that of targeted therapies and chemoprevention of breast cancer with the intent for advancement of innovation and translational science in clinical trials for Breast Cancer.

Dr. Bland is a sought after speaker; presenting at Medical Schools and teaching Universities around the country as well as serving the local community.

He is the author or co-author of almost 600 journal publications, author or editor of 44 textbooks, including the largest selling book on breast diseases, The Breast: Comprehensive Management of Benign and Malignant Diseases. Dr. Bland is currently an active editorial board member of 12 scientific peer-reviewed journals. Since January of 2005, he has served as the editor-in-chief of The American Journal of Surgery.

Society Memberships
Organization Name Position Held Org Link
American Board of Surgery  1992 Director   
American College of Surgeons  Fellow   
American College of Surgeons, Alabama Chapter  2009-2010 Vice President   
Society of Surgical Oncology  1996-1997 President   
Southeastern Surgical Congress  Member   
Southern Surgical Association  2006 President    

Research/Clinical Interest
Title
Development of novel retinoids
Description
Breast disease/cancer, colon/rectal disease/cancer

Selected Publications 
Publication PUBMEDID
Preserving surgical academia in the centenary of the Flexnerian Academic Health Center.
Bland KI.

Ann Surg. 2011 Sep;254(3):393-409. 
21865941 
Arch Surg. 2011 Feb;146(2):142.
Injection site mass following sentinel node biopsy for breast cancer.
Occurrence of prolonged injection site mass with methylene blue but not isosulfan blue after the sentinel node procedure.
Bland KI

Arch Surg. 2011 Feb;146(2):142. 
21442786 
Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor.
Chen J1, Yang S, Hu S, Choudhry MA, Bland KI, Chaudry IH.

Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G1131-7. 
18832446 
Mechanism of the salutary effects of estrogen on kupffer cell phagocytic capacity following trauma-hemorrhage: pivotal role of Akt activation.
Hsieh CH1, Nickel EA, Chen J, Schwacha MG, Choudhry MA, Bland KI, Chaudry IH.

J Immunol. 2009 Apr 1;182(7):4406-14. 
19299741 
Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling.
Liu Z1, Teng L, Bailey SK, Frost AR, Bland KI, LoBuglio AF, Ruppert JM, Lobo-Ruppert SM.

Cancer Biol Ther. 2009 Oct;8(19):1840-51.
 
19717984 
Salutary effects of 17beta-estradiol on Peyer's patch T cell functions following trauma-hemorrhage.
Kawasaki T1, Suzuki T, Choudhry MA, Bland KI, Chaudry IH.

Cytokine. 2010 Aug;51(2):166-72. 
20400328 
Detection of human cytomegalovirus in normal and neoplastic breast epithelium.
Harkins LE1, Matlaf LA, Soroceanu L, Klemm K, Britt WJ, Wang W, Bland KI, Cobbs CS.

Herpesviridae. 2010 Dec 23;1(1):8 
21429243 
L-methionine-induced alterations in molecular signatures in MCF-7 and LNCaP cancer cells.
Benavides MA1, Hu D, Baraoidan MK, Bruno A, Du P, Lin S, Yang W, Bland KI, Grizzle WE, Bosland MC.

J Cancer Res Clin Oncol. 2011 Mar;137(3):441-53.  
20454975 
L-Methionine inhibits growth of human pancreatic cancer cells.
Benavides MA1, Bosland MC, da Silva CP, Gomes Sares CT, de Oliveira AM, Kemp R, dos Reis RB, Martins VR, Sampaio SV, Bland KI, Grizzle WE, dos Santos JS.

Anticancer Drugs. 2014 Feb;25(2):200-3 
24126240 

Keywords
oncology, breast, tumor, cancer, school of medicine, training, research